Navigating the Canadian copyright scene presents a tricky challenge. To be blunt , dimethyltryptamine (copyright) remains strictly prohibited across this territory. There are no licensed sources accessible for acquisition . However, perhaps , the decriminalized status of psilocybin, and the expanding acceptance of copyright therapy , have triggered